Global X Management Company’s Jazz Pharmaceuticals JAZZ Stock Holding History

Global X Management Company’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$52K	Buy	299 +91	+44%	+$14.9K	﹤0.01%	1078
2018 Q1	$31K	Hold	208	–	–	﹤0.01%	1077
2017 Q4	$28K	Buy	208 +57	+38%	+$7.91K	﹤0.01%	1000
2017 Q3	$22K	Buy	151 +5	+3%	+$756	﹤0.01%	1056
2017 Q2	$23K	Buy	146 +11	+8%	+$1.68K	﹤0.01%	1123
2017 Q1	$20K	Buy	+135	New	+$17.6K	﹤0.01%	1074
2016 Q3	–	Sell	-352	Closed	-$50K	–	1094
2016 Q2	$50K	Buy	352 +209	+146%	+$30.8K	﹤0.01%	709
2016 Q1	$19K	Buy	143 +128	+853%	+$15.9K	﹤0.01%	794
2015 Q4	$2K	Sell	15 -17	-53%	-$2.36K	﹤0.01%	799
2015 Q3	$4K	Hold	32	–	–	﹤0.01%	792
2015 Q2	$6K	Buy	+32	New	+$5.75K	﹤0.01%	691

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Global X Management Company's JAZZ Position: Q2 2018 in Review

Global X Management Company increased its Jazz Pharmaceuticals (JAZZ) stake by 44% in Q2 2018, buying an estimated $14.9K and bringing the position to 299 shares worth $52K. The position accounts for ﹤0.01% of the portfolio, ranked #1078.

Global X Management Company first reported a position in JAZZ in Q2 2015 and has held it in 11 quarters since. 376 funds tracked by Wall St. Rank hold JAZZ as of Q2 2018.

Global X Management Company held 299 shares of Jazz Pharmaceuticals worth $52K as of Q2 2018.
Global X Management Company bought 91 Jazz Pharmaceuticals shares in Q2 2018, an estimated $14.9K.
Jazz Pharmaceuticals made up ﹤0.01% of Global X Management Company's portfolio in Q2 2018, its #1078 holding.
Global X Management Company first reported a position in Jazz Pharmaceuticals in Q2 2015 and has held it in 11 quarters since.
376 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2018.

Based on Global X Management Company's 13F filing for Q2 2018, filed 16 Aug 2018.